UBS Group Portfolio holdings
UBS Group is the Swiss bank holding company behind UBS, which was created in 1998 when Union Bank of Switzerland merged with Swiss Bank Corporation; the holding company was listed in New York in 2014. Its business spans wealth management, investment banking, asset management and banking for individuals and companies. Its asset management arm offers stock, bond, currency, hedge fund, real estate, infrastructure and private equity strategies, which can also be combined in multi-asset portfolios. The group's roots go back to the Bank in Winterthur, founded in 1862, and to Swiss Bank Corporation, started by six private bankers in Basel by 1854. The wealth management arm serves high net worth individuals worldwide, and its US business grew out of Paine Webber, the American brokerage UBS merged with in 2000 and renamed UBS Wealth Management USA in 2003. In 2023 UBS took over Credit Suisse in a rescue deal arranged by the Swiss government and central bank.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.15B |
| 2 |
HONA
Honeywell Aerospace
HONA
|
+$611M |
| 3 |
SpaceX
SPCX
|
+$567M |
| 4 |
Apple
AAPL
|
+$511M |
| 5 |
Jabil
JBL
|
+$463M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.49B |
| 2 |
Western Digital
WDC
|
+$1.42B |
| 3 |
Lumentum
LITE
|
+$951M |
| 4 |
Intel
INTC
|
+$785M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$749M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.93% |
| 2 | Technology | 18.61% |
| 3 | Financials | 7.85% |
| 4 | Industrials | 6.96% |
| 5 | Healthcare | 5.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
3326
Nuveen California Quality Municipal Income Fund
NAC
$1.63B
| $11M | ﹤0.01% |
906,262
-88,815
| -9% | -$1.06M |
2014 Q4
46 quarters
|
|
3327
Resideo Technologies
REZI
$2.95B
| $11M | ﹤0.01% |
353,112
-321,561
| -48% | -$11.1M |
2018 Q4
30 quarters
|
|
3328
PJT Partners
PJT
$3.8B
| $11M | ﹤0.01% |
72,715
+30,936
| +74% | +$4.77M |
2015 Q4
42 quarters
|
|
3329
Franklin BSP Realty Trust
FBRT
$469M
| $11M | ﹤0.01% |
1,346,899
+143,219
| +12% | +$1.24M |
2021 Q4
18 quarters
|
|
3330
Fidelity Enhanced Small Cap Core ETF
FESM
$6.53B
| $11M | ﹤0.01% |
226,814
+72,805
| +47% | +$3.2M |
2024 Q4
6 quarters
|
|
3331
United States Antimony
UAMY
$422M
| $11M | ﹤0.01% |
1,508,467
-504,109
| -25% | -$4.56M |
2024 Q2
8 quarters
|
|
3332
CALL
Waste Management
WM
$93.9B
| $10.9M | ﹤0.01% |
49,100
-43,700
| -47% | -$9.7M |
2025 Q1
5 quarters
|
|
3333
PUT
KeyCorp
KEY
$22B
| $10.9M | ﹤0.01% |
474,700
-75,000
| -14% | -$1.63M |
2024 Q4
6 quarters
|
|
3334
iShares MSCI Saudi Arabia ETF
KSA
$566M
| $10.9M | ﹤0.01% |
293,152
+107,791
| +58% | +$4.19M |
2021 Q1
21 quarters
|
|
3335
LegalZoom.com
LZ
$865M
| $10.9M | ﹤0.01% |
1,784,142
+363,942
| +26% | +$2.23M |
2022 Q3
15 quarters
|
|
3336
PUT
Tyson Foods
TSN
$21B
| $10.9M | ﹤0.01% |
191,000
-111,900
| -37% | -$7M |
2025 Q1
5 quarters
|
|
3337
PUT
The Mosaic Company
MOS
$7.11B
| $10.9M | ﹤0.01% |
515,600
+422,000
| +451% | +$9.8M |
2024 Q2
8 quarters
|
|
3338
WIX.com
WIX
$3.18B
| $10.9M | ﹤0.01% |
240,718
-18,877
| -7% | -$1.17M |
2016 Q1
41 quarters
|
|
3339
iShares Morningstar Small-Cap Growth ETF
ISCG
$935M
| $10.9M | ﹤0.01% |
166,628
-200
| -0.1% | -$12.2K |
2014 Q4
46 quarters
|
|
3340
Vera Therapeutics
VERA
$2.15B
| $10.9M | ﹤0.01% |
254,182
+66,295
| +35% | +$2.47M |
2022 Q1
17 quarters
|
|
3341
iShares US Pharmaceuticals ETF
IHE
$1.6B
| $10.9M | ﹤0.01% |
110,100
+70,420
| +177% | +$6.35M |
2014 Q4
46 quarters
|
|
3342
GeoPark
GPRK
$1.01B
| $10.9M | ﹤0.01% |
1,196,705
+192,466
| +19% | +$1.87M |
2018 Q1
33 quarters
|
|
3343
Kulicke & Soffa
KLIC
$3.35B
| $10.9M | ﹤0.01% |
81,337
-234
| -0.3% | -$22.9K |
2014 Q4
46 quarters
|
|
3344
PUT
Everpure Inc
P
$32.2B
| $10.9M | ﹤0.01% |
137,800
+20,900
| +18% | +$1.53M |
2024 Q3
7 quarters
|
|
3345
Nuveen ESG International Developed Markets Equity ETF
NUDM
$881M
| $10.9M | ﹤0.01% |
271,289
+129,002
| +91% | +$4.98M |
2017 Q4
34 quarters
|
|
3346
iShares Convertible Bond ETF
ICVT
$7.22B
| $10.8M | ﹤0.01% |
89,109
-1,157
| -1% | -$134K |
2021 Q2
20 quarters
|
|
3347
PUT
AstraZeneca
AZN
$289B
| $10.8M | ﹤0.01% |
57,200
-100,000
| -64% | -$18.8M |
2026 Q1
1 quarter
|
|
3348
Ziff Davis
ZD
$1.7B
| $10.8M | ﹤0.01% |
206,880
+391
| +0.2% | +$17.7K |
2014 Q4
46 quarters
|
|
3349
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$673M
| $10.8M | ﹤0.01% |
94,240
+61,176
| +185% | +$6.71M |
2014 Q4
46 quarters
|
|
3350
BlackLine
BL
$1.5B
| $10.8M | ﹤0.01% |
383,387
-2,819,911
| -88% | -$84.3M |
2016 Q4
38 quarters
|
|
Similar funds
UBS Group's Q2 2026 Portfolio in Review
As of Q2 2026, UBS Group held 11,684 positions worth $786B, up 18% from $666B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
UBS Group's Q2 2026 filing shows 1,281 new, 4,217 increased, 4,362 reduced and 1,275 closed positions. Its largest new stake was Honeywell Aerospace: 2,768,136 shares worth $612M. The largest sale was ExxonMobil, an estimated $1.49B.
By sector, the portfolio is most concentrated in Miscellaneous at 42% of assets, up from 39% a quarter earlier, followed by Technology and Financials.
- UBS Group's largest Q2 2026 buy was Honeywell Aerospace: 2,768,136 shares worth $612M.
- UBS Group added most to Microsoft in Q2 2026, an estimated $1.15B increase.
- UBS Group's biggest Q2 2026 reduction was ExxonMobil, cutting an estimated $1.49B.
- UBS Group fully exited Hologic in Q2 2026, selling an estimated $385M.
- UBS Group's ten largest holdings make up 13% of its $786B portfolio in Q2 2026.
- UBS Group opened 1,281 new positions and closed 1,275 in Q2 2026.
- UBS Group's portfolio value rose 18% quarter-over-quarter to $786B.
Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.